Yes, and it acts on a second receptor as well. Zepbound is tirzepatide, which activates the GIP receptor alongside the GLP-1 receptor; semaglutide, liraglutide and dulaglutide act on the GLP-1 receptor alone.

No. Zepbound is a GIP and GLP-1 receptor agonist, not insulin: it acts on the body's own insulin release rather than replacing insulin. That is why these drugs' labels warn of low blood sugar mainly when they are taken with insulin or a sulfonylurea.

Does Zepbound come in a pill?

No. Zepbound is an injection, and no pill of tirzepatide is among the products tracked here.

What is Zepbound?

What is Zepbound, and how does it work?

Zepbound (tirzepatide) is an injection made by Eli Lilly, whose active ingredient is tirzepatide. FDA approved for chronic weight management and obstructive sleep apnea. It activates two gut-hormone receptors at once — GIP and GLP-1 — which together regulate appetite and how much food is eaten. In its pivotal trial it produced 20.9% mean weight loss. It costs $449 a month once titrated, read from its own published page on 2026-08-19, 54 days ago and past the 45-day window — the maintenance rate rather than the starting dose, because the starting dose is not the dose anyone stays on.

How does Zepbound work? The label's words

Tirzepatide is a GIP receptor and GLP-1 receptor agonist. It contains a C20 fatty diacid that enables albumin binding and prolongs the half-life. Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1. GLP-1 is a physiological regulator of appetite and caloric intake. Nonclinical studies suggest the addition of GIP may further contribute to the regulation of food intake.

Quoted from the mechanism of action section of FDA prescribing information for ZEPBOUND, read 2026-08-29. Not paraphrased: how a drug works is the last thing a price site should put in its own words.

What is Zepbound approved for?

Chronic weight management
To reduce excess body weight and maintain weight reduction long term in adults with obesity, or adults with overweight in the presence of at least one weight-related comorbid condition, in combination with a reduced-calorie diet and increased physical activity.
Obstructive sleep apnea
To treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This is a separate approved indication, not an off-label use, and it is the one that changes the conversation with a plan that excludes weight-loss drugs.

Approvals are quoted from the label, because the wording is what a prior authorization is judged against. Which approval a plan cannot exclude — a weight-loss exclusion is written against the use, not the molecule.

How much weight did Zepbound lose in its trial?

20.9% of body weight. SURMOUNT-1, Study 1 on the label, 72 weeks: 20.9% mean weight loss at 15 mg against 3.1% on placebo, intention-to-treat.

One trial, one protocol, one population. Comparing it with another drug's figure compares two separate experiments rather than two drugs — the comparison, and what a point of body weight costs.

It carries a boxed warning — the strongest the FDA issues

In rodents this molecule caused thyroid C-cell tumors at human-relevant doses. Whether it does so in people is unknown, and the label carries that as a boxed warning. It is contraindicated outright with a personal or family history of medullary thyroid carcinoma or MEN 2.

Everything the label lists, including who cannot take it →

How much does Zepbound cost?

$449 a month once titrated, read from its own published page on 2026-08-19, 54 days ago and past the 45-day window. The starting dose is usually cheaper and nobody stays on it, which is why the maintenance figure is the one this site records.

Zepbound price and terms →The cheapest way to get it →

No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price

Zepbound, answered

Is Zepbound a GLP-1?: Yes, and it acts on a second receptor as well. Zepbound is tirzepatide, which activates the GIP receptor alongside the GLP-1 receptor; semaglutide, liraglutide and dulaglutide act on the GLP-1 receptor alone.
Is Zepbound insulin?: No. Zepbound is a GIP and GLP-1 receptor agonist, not insulin: it acts on the body's own insulin release rather than replacing insulin. That is why these drugs' labels warn of low blood sugar mainly when they are taken with insulin or a sulfonylurea.
Does Zepbound come in a pill?: No. Zepbound is an injection, and no pill of tirzepatide is among the products tracked here.

Everything on Zepbound

Last updated 2026-08-29 — the FDA label this page quotes. Read and dated by Alex Seot.